
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
[ Mon, Nov 05th 2018 ]: WOPRAI
David Risinger Upgraded (TEVA) to Buy and Held Target at $27 on, Nov 5th, 2018


🞛 This publication is a summary or evaluation of another publication
David Risinger of Morgan Stanley, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy and Held Target at $27 on, Nov 5th, 2018.
David has made no other calls on TEVA in the last 4 months.
There are 8 other peers that have a rating on TEVA. Out of the 8 peers that are also analyzing TEVA, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ami Fadia of "Leerink Swann" Upgraded from Sell to Hold on, Monday, October 1st, 2018
- Tim Chiang of "BTIG" Upgraded from Strong Sell to Hold on, Monday, September 17th, 2018
- Vamil Divan of "Credit Suisse" Maintained at Hold with Increased Target to $26 on, Monday, September 17th, 2018
- Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $23 on, Monday, August 6th, 2018
- Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $25 on, Monday, July 16th, 2018
These are the ratings of the 3 analyists that currently disagree with David
- Jason Gerberry of "B of A Securities" Maintained at Sell with Increased Target to $20 on, Friday, November 2nd, 2018
- Jami Rubin of "Goldman Sachs" Maintained at Strong Buy and Held Target at $30 on, Monday, October 1st, 2018
- Irina Rivkind Koffler of "Mizuho" Maintained at Strong Buy with Increased Target to $29 on, Monday, September 17th, 2018
Similar Stocks and Investing Publications
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Mon, Oct 01st 2018 ]: WOPRAI
[ Mon, Oct 01st 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Thu, Jan 18th 2018 ]: WOPRAI
[ Tue, Jan 09th 2018 ]: WOPRAI
[ Fri, Jan 05th 2018 ]: WOPRAI
[ Thu, Jan 04th 2018 ]: WOPRAI
[ Tue, Jan 02nd 2018 ]: WOPRAI